Medical Marijuana Market to Experience Blatant Growth at 35.4% of CAGR during the Forecast Period 2019-2023

According to Market Research Future, the Global Medical Marijuana Market to provide readers with a clear view of the market’s likely growth trajectory over the coming years. The report utilizes historical trends of the Global Medical Marijuana Market and present statistics to derive.

Pune, India - February 12, 2019 /MarketersMedia/ —

Medical Marijuana Market - Synopsis

Global Medical Marijuana Market is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.

Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6470

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.

Top Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).

The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.

The market, by distribution channel, has been segmented into dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Some Points From TOC of Medical Marijuana Market Research Report – Forecast to 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…!

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Source URL: https://marketersmedia.com/medical-marijuana-market-to-experience-blatant-growth-at-354-of-cagr-during-the-forecast-period-2019-2023/481621

Source: MarketersMedia

Release ID: 481621

Latest News

New indictment expands case against Nissan ex-chair Ghosn

Apr 22, 2019

TOKYO — Japanese prosecutors said Monday they have indicted Nissan's former chairman Carlos Ghosn with additional charges of breach of trust, with his alleged misconduct expanding outside Japan. The charges filed Monday are his fourth. They are related to payments by a subsidiary of the Japanese automaker that allegedly went to a private investment company controlled by Ghosn. Prosecutors would not confirm details of the charges. The indictment was expected and it ensures he will remain in detention longer. His current period of detention would have expired Monday if he had not been charged. Nissan Motor Co. said Monday in...

Asian markets lower, oil rises on Iran concerns

Apr 22, 2019

BEIJING — Asian stock markets were mostly lower while oil prices surged for a second day Monday following reports Washington wants to block Iranian exports. Tokyo's benchmark edged up while Shanghai, Seoul and India retreated. Hong Kong and Sydney were closed for the holiday. On Wall Street, the benchmark Standard & Poor's 500 index ended a shortened trading week Thursday snapping a winning streak of three weekly gains. Investors looked ahead to U.S. quarterly gross domestic product due out Friday. Also this week, the United States reports new home sales Tuesday while Japan announces factory output on Friday. "The broad...

China's Huawei says 1Q sales up 39%

Apr 22, 2019

BEIJING — Chinese tech giant Huawei said Monday its revenue rose 39% over a year earlier in the latest quarter despite U.S. pressure on allies to shun its telecom technology as a security risk. Huawei, the biggest global maker of network equipment for phone and internet companies, on Monday reported revenue of 179.7 billion yuan ($26.8 billion) for the first three months of the year. Washington's pressure on allies to avoid Huawei, China's first global tech brand, threatens to block access to Europe and other markets as carriers prepare to invest billions of dollars in next-generation technology. The company denies...

Asian markets mixed in post-Easter trading

Apr 22, 2019

BEIJING — Asian stock markets were mixed Monday following the Easter holiday weekend as investors looked ahead to U.S. and Japanese economic data. Benchmarks in Tokyo and Seoul gained while Shanghai retreated. Hong Kong and Sydney were closed for the holiday. On Wall Street, the benchmark Standard & Poor's 500 index ended a shortened trading week on Thursday snapping a winning streak of three weekly gains. Investors looked ahead to U.S. quarterly gross domestic product due out Friday. The United States reports new home sales Tuesday while Japan announces factory output on Friday. "The broad expectation is for U.S. indices...

Liverpool returns to top spot; Everton humiliates Man United

Apr 22, 2019

LONDON — Before returning to the top of the Premier League, Liverpool got to savor a Manchester United humiliation. Now, unusually, Liverpool needs a swift recovery by its great rival after United's despair at being routed 4-0 by Everton on Sunday. Liverpool's hopes of ending a 29-year English title drought could hinge on a big favor from sixth-place United when it hosts Manchester City on Wednesday. After beating Cardiff 2-0 on Sunday, Liverpool is two points ahead of City with three games remaining. But Pep Guardiola's champions have a game in hand over Liverpool so defending the title is still...

About Us

Frontal Report is an emerging leader in all forms of media. We aim to be the leading news brand for readers around the world.

Contact us: sales[at]frontalreport.com

Subscribe Now!